Skip to content

CareDx CDNA Total Cost of Revenue

Total Cost of Revenue at other companies

NeoGenomics logo
NeoGenomicsNEO
$105.81M+11.6%
Personalis, Inc. logo
Personalis, Inc.PSNL
$15.19M+13.4%
GeneDx Holdings logo
GeneDx HoldingsWGS
$34.04M+18.9%
TransMedics Group, Inc. logo
TransMedics Group, Inc.TMDX
$72.77M+31.6%
Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO
$282.7M+1.2%
Natera, Inc. logo
Natera, Inc.NTRA

Segments

By product

See full
Testing services revenue$17.1M+13.1%
Patient and digital solutions revenue$11.7M+51.6%

Other financials

Income statement

See full
Revenue$117.7M+39.0%
Operating income$1.2M+109%
Net income$2.8M+127%
EPS (diluted)$0.05+126%

Balance sheet

See full
Cash & equivalents$78.5M-12.1%
Total debt$24.5M-19.1%
Total equity$313.5M-17.3%
Total assets$411.1M-16.0%

Cash flow

See full
Operating cash flow$4.3M+116%
CapEx$3.8M+134%
Free cash flow$514.0K+102%

Valuation

See full
Market cap$1.4B+32.2%
Enterprise value$1.35B+34.6%
P/S3.4×+0.3×

Profitability

See full
Gross margin65.5%
Operating margin-3.9%-18.3pp
Net margin-2%-19.9pp
FCF margin-0%0.0pp

Returns & leverage

See full
Return on equity-2.4%-21.9pp
Debt / equity0.1×0.0×
Current ratio3.4×-0.7×

Where this comes from

Reported directly by CareDx in its filing.

Tagged under the XBRL concept us-gaap:CostOfRevenue.

The official record: CareDx’s 10-Q, filed August 4, 2020, on SEC EDGAR. View the filing →

Questions, answered.

What does total cost of revenue mean?
The aggregate of all direct costs attributable to producing goods and delivering services that generated the company's revenue, including materials, labor, and overhead.